TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

被引：15

作者：

Hiwase, Devendra ^{[1
,2
,3
,4
,5
]}

Hahn, Christopher ^{[4
,5
,7
]}

Tran, Elizabeth Ngoc Hoa ^{[2
,3
]}

Chhetri, Rakchha ^{[1
,2
,3
]}

Baranwal, Anmol ^{[6
]}

Al-Kali, Aref ^{[6
]}

Sharplin, Kirsty ^{[1
]}

Ladon, Dariusz ^{[7
]}

Hollins, Rachel ^{[7
]}

Greipp, Patricia ^{[8
]}

Kutyna, Monika ^{[1
,2
,3
]}

Alkhateeb, Hassan ^{[6
]}

Badar, Talha ^{[9
]}

Wang, Paul ^{[10
]}

Ross, David M. ^{[1
,2
,3
,4
,5
]}

Singhal, Deepak ^{[1
,2
]}

Shanmuganathan, Naranie ^{[1
,2
]}

Bardy, Peter ^{[1
]}

Beligaswatte, Ashanka ^{[1
]}

Yeung, David ^{[1
,2
]}

Litzow, Mark R. ^{[6
]}

Mangaonkar, Abhishek ^{[6
]}

Giri, Pratyush ^{[1
]}

Lee, Cindy ^{[1
]}

Yong, Angie ^{[1
]}

Horvath, Noemi ^{[1
]}

Singhal, Nimit ^{[1
]}

Gowda, Raghu ^{[1
]}

Hogan, William ^{[6
]}

Gangat, Naseema ^{[6
]}

Patnaik, Mrinal ^{[6
]}

Begna, Kebede ^{[6
]}

Tiong, Ing S. ^{[11
,12
]}

Wei, Andrew ^{[11
,12
]}

Kumar, Sharad ^{[4
,5
]}

Brown, Anna ^{[4
,5
,7
]}

Scott, Hamish ^{[4
,5
,7
]}

Thomas, Daniel ^{[1
,2
,3
]}

Kok, Chung H. ^{[2
,3
]}

Tefferi, Ayalew ^{[6
]}

Shah, Mithun Vinod

机构：

[1] Royal Adelaide Hosp, Cent Adelaide Local Hlth Network, Dept Haematol, Adelaide, SA, Australia

[2] South Australian Hlth & Med Res Inst SAHMRI, Precis Med Theme, Adelaide, SA, Australia

[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia

[4] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia

[5] SA Pathol, Adelaide, SA, Australia

[6] Mayo Clin Rochester, Div Hematol, Rochester, MN 55906 USA

[7] SA Pathol, Genet & Mol Pathol, Adelaide, SA, Australia

[8] Mayo Clin Rochester, Lab Med & Pathol, Rochester, MN 55906 USA

[9] Mayo Clin Jacksonville, Dept Hematol Oncol, Jacksonville, FL USA

[10] SA Pathol, ACRF Canc Genom Facil, Adelaide, SA, Australia

[11] Alfred Hosp, Dept Haematol, Melbourne, Vic, Australia

[12] Monash Univ, Melbourne, Vic, Australia

来源：

BLOOD | 2023年 / 141卷 / 09期

基金：

澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;

关键词：

D O I：

10.1182/blood.2022018236

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1087 / 1091

页数：5

共 50 条

[21] Polymorphisms in MDM2 and TP53 Genes and Risk of Developing Therapy-Related Myeloid Neoplasms
Maria Cabezas
Lydia García-Quevedo
Cintia Alonso
Marta Manubens
Yolanda Álvarez
Joan Francesc Barquinero
Santiago Ramón y Cajal
Margarita Ortega
Adoración Blanco
María Rosa Caballín
Gemma Armengol
Scientific Reports, 9
[22] De Novo and Therapy-Related Pure Erythroid Leukemia Harbor Distinct TP53 Genetic Alterations
Tashakori, Mehrnoosh
Wang, Wei
Wang, Sa
Kanagal-Shamanna, Rashmi
Loghavi, Sanam
Medeiros, L. Jeffrey
Tapan, Kadia
Daver, Naval
Ravandi-Kashani, Farhad
Khoury, Joseph
MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 898 - 900
[23] Polymorphisms in MDM2 and TP53 Genes and Risk of Developing Therapy-Related Myeloid Neoplasms
Cabezas, Maria
Garcia-Quevedo, Lydia
Alonso, Cintia
Manubens, Marta
Alvarez, Yolanda
Francesc Barquinero, Joan
Ramon y Cajal, Santiago
Ortega, Margarita
Blanco, Adoracion
Rosa Caballin, Maria
Armengol, Gemma
SCIENTIFIC REPORTS, 2019, 9 (1)
[24] The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML
Wong, Terrence Neal
Ramsingh, Giridharan
Young, Andrew
Shen, Dong
Miller, Chris
Lamprecht, Tamara
Heath, Sharon
Fulton, Robert S.
Mardis, Elaine R.
Ding, Li
Westervelt, Peter
Welch, John
Walter, Matthew J.
Graubert, Timothy
DiPersio, John F.
Ley, Timothy J.
Druley, Todd E.
Wilson, Richard K.
Link, Daniel C.
BLOOD, 2013, 122 (21)
[25] TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation
George, Binsah
Kantarjian, Hagop
Baran, Natalia
Krocker, Joseph Douglas
Rios, Adan
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
[26] TP53 mutation status defines two distinct classes of diffuse anaplastic Wilms tumor
Maschietto, Mariana
Chagtai, Tasnim
Popov, Sergey D.
Sebire, Neil
Vujanic, Gordan
Hing, Sandra
Grundy, Paul
Dome, Jeffrey S.
Pritchard-Jones, Kathy
Williams, Richard D.
CANCER RESEARCH, 2013, 73 (08)
[27] COMPARISON TP53 MUTATION SITES IN BLAST PHASE OF MYELOPROLIFERATIVE NEOPLASM AND ACUTE MYELOID LEUKEMIA
Chen, Dong
Cantu, Miguel
Siddon, Alexa
Weinberg, Olga
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 : 24 - 24
[28] Risk of therapy-related subsequent cancers in individuals with germline TP53 variants
Villani, Anita
Khincha, Payal
Hatton, Jessica
Schonfeld, Sara
Goudie, Catherine
Oba, Leatrisse
Pithadia, Kishan
Sanger, Birte
Kratz, Christian
Le, Anh N.
Orr, Caitlin
Maxwell, Kara N.
Naumer, Anne
Vagher, Jennie
Kohlmann, Wendy
Schi, Joshua
dos Santos, Elizabeth Santana
Michaeli, Orli
Carson, Jacob J.
Tsang, Derek S.
Kim, Raymond
Maciaszek, Jamie L.
Nichols, Kim E.
Goodman, Victoria E.
MacFarland, Suzanne P.
Reichman, Lara
Achatz, Maria Isabel
Savage, Sharon
Malkin, David
Morton, Lindsay M.
CANCER RESEARCH, 2024, 84 (17)
[29] TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
Silwal-Pandit, Laxmi
Vollan, Hans Kristian Moen
Chin, Suet-Feung
Rueda, Oscar M.
McKinney, Steven
Osako, Tomo
Quigley, David A.
Kristensen, Vessela N.
Aparicio, Samuel
Borresen-Dale, Anne-Lise
Caldas, Carlos
Langerod, Anita
CLINICAL CANCER RESEARCH, 2014, 20 (13) : 3569 - 3580
[30] TP53-mutated Acute Myeloid Leukemia with Myelodysplasia-Related Changes and Therapy-Related Acute Myeloid Leukemia Have Comparable TP53 Mutational Signature and Clinical Features
Tashakori, Mehrnoosh
Tapan, Kadia
Loghavi, Sanam
Tang, Zhenya
Routbort, Mark
Ravandi-Kashani, Farhad
Khoury, Joseph
LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1027 - 1028

← 1 2 3 4 5 →